HomeCompareEXIV vs MO

EXIV vs MO: Dividend Comparison 2026

EXIV yields 26.85% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXIV wins by $32.5K in total portfolio value
10 years
EXIV
EXIV
● Live price
26.85%
Share price
$7.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$110.1K
Annual income
$13,226.96
Full EXIV calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — EXIV vs MO

📍 EXIV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXIVMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXIV + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXIV pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXIV
Annual income on $10K today (after 15% tax)
$2,281.88/yr
After 10yr DRIP, annual income (after tax)
$11,242.92/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, MO beats the other by $13,380.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXIV + MO for your $10,000?

EXIV: 50%MO: 50%
100% MO50/50100% EXIV
Portfolio after 10yr
$93.9K
Annual income
$21,097.75/yr
Blended yield
22.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

EXIV
No analyst data
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXIV buys
0
MO buys
0
No recent congressional trades found for EXIV or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXIVMO
Forward yield26.85%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$110.1K$77.7K
Annual income after 10y$13,226.96$28,968.54
Total dividends collected$71.9K$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EXIV vs MO ($10,000, DRIP)

YearEXIV PortfolioEXIV Income/yrMO PortfolioMO Income/yrGap
1← crossover$13,385$2,684.56$10,558$768.31+$2.8KEXIV
2$17,680$3,358.10$11,352$1,015.87+$6.3KEXIV
3$23,063$4,145.51$12,482$1,367.86+$10.6KEXIV
4$29,731$5,053.96$14,103$1,883.39+$15.6KEXIV
5$37,901$6,089.03$16,472$2,664.91+$21.4KEXIV
6$47,809$7,254.51$20,024$3,897.79+$27.8KEXIV
7$59,708$8,552.22$25,537$5,933.74+$34.2KEXIV
8$73,869$9,982.00$34,478$9,476.77+$39.4KEXIV
9$90,582$11,541.62$49,776$16,022.63+$40.8KEXIV
10$110,149$13,226.96$77,699$28,968.54+$32.5KEXIV

EXIV vs MO: Complete Analysis 2026

EXIVStock

The investment seeks to link to the VSTOXX Short-Term Futures Inverse Investable Index (the “Inverse Investable Index”). The Inverse Investable Index replicates the performance of a short position in a portfolio of VSTOXX futures designed to provide a short exposure to constant-maturity one-month forward, one-month implied volatilities on the underlying EURO STOXX 50 Index, taking into account the bid-ask spread in the roll procedure and the daily reset costs, which will reduce the value of the Inverse Securities.

Full EXIV Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this EXIV vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXIV vs SCHDEXIV vs JEPIEXIV vs OEXIV vs KOEXIV vs MAINEXIV vs PMEXIV vs BTIEXIV vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.